Base Invaders

The standard approach for extraction of poly(A)+ RNA from cell lysates is by oligo(dT) cellulose affinity chromatography. However, recent advances in peptide nucleic acid chemistry have produced another method for poly(A)+ RNA extraction. This novel technology uses phosphono-peptide nucleic acids (pPNA). These molecules are similar to DNA except A, T, G, or C bases are covalently attached to an N-(2-aminoethyl) glycine backbone.1 Water-soluble pPNAs hybridize to both DNA and RNA but are not degr

Written byGregory Smutzer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The standard approach for extraction of poly(A)+ RNA from cell lysates is by oligo(dT) cellulose affinity chromatography. However, recent advances in peptide nucleic acid chemistry have produced another method for poly(A)+ RNA extraction. This novel technology uses phosphono-peptide nucleic acids (pPNA). These molecules are similar to DNA except A, T, G, or C bases are covalently attached to an N-(2-aminoethyl) glycine backbone.1 Water-soluble pPNAs hybridize to both DNA and RNA but are not degraded by nucleases or peptidases.

Active Motif of Carlsbad, Calif., now offers mVADER, the first commercially available kit that utilizes biotinylated oligo(T) pPNA to capture poly(A)+ RNA. One of the strengths of the system, according to Dorothy Phelan, senior scientist at Active Motif, is that the invasive clamping pPNAs can bind to mRNA molecules that contain extensive secondary structure and form stable complexes with shorter poly(A) tails than does oligo(dT) cellulose. These unique properties of pPNAs allow ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies